0 Évaluations

ID

16684

Description

HuMax-CD20 in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00093314

Lien

https://clinicaltrials.gov/show/NCT00093314

Mots-clés

  1. 31/07/2016 31/07/2016 -
  2. 01/08/2016 01/08/2016 -
Téléchargé le

1 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Chronic Lymphocytic Leukemia NCT00093314

    Eligibility Chronic Lymphocytic Leukemia NCT00093314

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    chronic lymphocytic leukemia
    Description

    Chronic Lymphocytic Leukemia

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023434
    circulating lymphocytes above a specific level
    Description

    Increased number of circulating lymphocytes

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1849238
    circulating lymphocytes showing certain markers
    Description

    Lymphocyte Circulating | Lymphocyte markers

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0024264
    UMLS CUI [1,2]
    C0175630
    UMLS CUI [2]
    C0023158
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    previous treatment with rituximab or alemtuzumab within 6 months prior to enrollment in study.
    Description

    rituximab | alemtuzumab

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0393022
    UMLS CUI [2]
    C0383429
    previous stem cell transplantation.
    Description

    Stem cell transplant

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1504389
    received any of the following treatments within 4 weeks prior to entering this trial: a) anti-cancer therapy, b) glucocorticoids unless less than 10 mg per day, c) radiotherapy.
    Description

    cancer treatment | Glucocorticoids | Therapeutic radiology procedure

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0920425
    UMLS CUI [2]
    C0017710
    UMLS CUI [3]
    C1522449
    hiv positivity.
    Description

    HIV Seropositivity

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019699
    hepatitis b or hepatitis c.
    Description

    Hepatitis B | Hepatitis C

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019163
    UMLS CUI [2]
    C0019196
    other cancerous diseases, except certain skin cancers and cervix cancer.
    Description

    Malignant Neoplasms | Skin carcinoma | Cervix carcinoma

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    UMLS CUI [2]
    C0699893
    UMLS CUI [3]
    C0302592
    certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, heart, hormonal, nerve or blood diseases.
    Description

    medical condition Serious | Kidney Diseases | Liver diseases | Mental disorders | Stomach Diseases | Heart Diseases | Endocrine System Diseases | nervous system disorder | Hematological Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C3843040
    UMLS CUI [1,2]
    C0205404
    UMLS CUI [2]
    C0022658
    UMLS CUI [3]
    C0023895
    UMLS CUI [4]
    C0004936
    UMLS CUI [5]
    C0038354
    UMLS CUI [6]
    C0018799
    UMLS CUI [7]
    C0014130
    UMLS CUI [8]
    C0027765
    UMLS CUI [9]
    C0018939
    participation in another trial with a different new drug 4 weeks prior to enrollment in study.
    Description

    Study Subject Participation Status | Investigational New Drug Different

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    UMLS CUI [2,1]
    C0013230
    UMLS CUI [2,2]
    C1705242
    current participation in any other clinical study.
    Description

    Study Subject Participation Status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    pregnant or breast-feeding women.
    Description

    Pregnancy | Breast Feeding

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    women of childbearing age who are unable or unwilling to use adequate contraception.
    Description

    Childbearing Potential Age | Contraceptive methods Unwilling

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C3831118
    UMLS CUI [1,2]
    C0001779
    UMLS CUI [2,1]
    C0700589
    UMLS CUI [2,2]
    C0558080

    Similar models

    Eligibility Chronic Lymphocytic Leukemia NCT00093314

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Chronic Lymphocytic Leukemia
    Item
    chronic lymphocytic leukemia
    boolean
    C0023434 (UMLS CUI [1])
    Increased number of circulating lymphocytes
    Item
    circulating lymphocytes above a specific level
    boolean
    C1849238 (UMLS CUI [1])
    Lymphocyte Circulating | Lymphocyte markers
    Item
    circulating lymphocytes showing certain markers
    boolean
    C0024264 (UMLS CUI [1,1])
    C0175630 (UMLS CUI [1,2])
    C0023158 (UMLS CUI [2])
    Item Group
    C0680251 (UMLS CUI)
    rituximab | alemtuzumab
    Item
    previous treatment with rituximab or alemtuzumab within 6 months prior to enrollment in study.
    boolean
    C0393022 (UMLS CUI [1])
    C0383429 (UMLS CUI [2])
    Stem cell transplant
    Item
    previous stem cell transplantation.
    boolean
    C1504389 (UMLS CUI [1])
    cancer treatment | Glucocorticoids | Therapeutic radiology procedure
    Item
    received any of the following treatments within 4 weeks prior to entering this trial: a) anti-cancer therapy, b) glucocorticoids unless less than 10 mg per day, c) radiotherapy.
    boolean
    C0920425 (UMLS CUI [1])
    C0017710 (UMLS CUI [2])
    C1522449 (UMLS CUI [3])
    HIV Seropositivity
    Item
    hiv positivity.
    boolean
    C0019699 (UMLS CUI [1])
    Hepatitis B | Hepatitis C
    Item
    hepatitis b or hepatitis c.
    boolean
    C0019163 (UMLS CUI [1])
    C0019196 (UMLS CUI [2])
    Malignant Neoplasms | Skin carcinoma | Cervix carcinoma
    Item
    other cancerous diseases, except certain skin cancers and cervix cancer.
    boolean
    C0006826 (UMLS CUI [1])
    C0699893 (UMLS CUI [2])
    C0302592 (UMLS CUI [3])
    medical condition Serious | Kidney Diseases | Liver diseases | Mental disorders | Stomach Diseases | Heart Diseases | Endocrine System Diseases | nervous system disorder | Hematological Disease
    Item
    certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, heart, hormonal, nerve or blood diseases.
    boolean
    C3843040 (UMLS CUI [1,1])
    C0205404 (UMLS CUI [1,2])
    C0022658 (UMLS CUI [2])
    C0023895 (UMLS CUI [3])
    C0004936 (UMLS CUI [4])
    C0038354 (UMLS CUI [5])
    C0018799 (UMLS CUI [6])
    C0014130 (UMLS CUI [7])
    C0027765 (UMLS CUI [8])
    C0018939 (UMLS CUI [9])
    Study Subject Participation Status | Investigational New Drug Different
    Item
    participation in another trial with a different new drug 4 weeks prior to enrollment in study.
    boolean
    C2348568 (UMLS CUI [1])
    C0013230 (UMLS CUI [2,1])
    C1705242 (UMLS CUI [2,2])
    Study Subject Participation Status
    Item
    current participation in any other clinical study.
    boolean
    C2348568 (UMLS CUI [1])
    Pregnancy | Breast Feeding
    Item
    pregnant or breast-feeding women.
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Childbearing Potential Age | Contraceptive methods Unwilling
    Item
    women of childbearing age who are unable or unwilling to use adequate contraception.
    boolean
    C3831118 (UMLS CUI [1,1])
    C0001779 (UMLS CUI [1,2])
    C0700589 (UMLS CUI [2,1])
    C0558080 (UMLS CUI [2,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial